Utility of serological screening for measles, mumps and rubella in immunocompromised patients.
Laura SticchiM AstengoI G IavaroneGiancarlo IcardiPublished in: Human vaccines & immunotherapeutics (2019)
Marchi et al. in their article (Measles in pregnancy: a threat for Italian women? Hum Vaccin Immunother. 2019 Jun 20:1-3) observed that 96.9% of pregnant women were positive for anti-measles IgG (with a higher risk of contracting measles in those aged 19-29 years) emphasizing the importance of serological screening before pregnancy. We evaluated seroprotection/seropositivity rates to Measles, Mumps and Rubella in 324 adults with an acquired immune-deficiency needing an immunization program. We found that younger patients (20-29 years) had a seroprevalence below 85%. Overall, a relevant proportion (21.6%, 54/250) of patients was susceptible to at least one infection needing immunization. Our results confirm the usefulness of proper strategies for identifying individuals susceptible to vaccine-preventable infections and protecting them through vaccination.
Keyphrases
- end stage renal disease
- pregnant women
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- emergency department
- type diabetes
- pregnancy outcomes
- metabolic syndrome
- intensive care unit
- polycystic ovary syndrome
- adipose tissue
- electronic health record
- mechanical ventilation